In AD, cAMP levels are generally reduced, although sometimes elevated or unchanged, depending on the expression/activity of AC and PDE in specific brain regions, which may contribute to AD pathogenesis (Kelly, 2018; Di Benedetto et al., 2021). The gene discussed is ASAH1; the disease is Alzheimer disease.